Cytokinetics Highlights Progress of Activities Directed to Muscle Biology at Today's Research & Development Day
07:00 EST 12 Dec 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Two First-In-Class Programs Advancing in Phase IIb Clinical Trials Company Convenes Panel of Experts to Discuss the Integrated Care of ALS Patients South San Francisco, CA, December 12, 2012 - Cytokinetics, Incorporated (Nasdaq: CYTK) is scheduled t...
Other Sources for this Article
More From BioPortfolio on "Cytokinetics Highlights Progress of Activities Directed to Muscle Biology at Today's Research & Development Day"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
